The global oncolytic virotherapy market is expanding rapidly, driven by advancements in cancer immunotherapy and rising demand for targeted treatments. Key trends include increased R&D investments, strategic collaborations, and clinical trials for novel therapies. North America leads, while Asia-Pacific shows growth potential due to rising cancer prevalence and healthcare improvements. More Info: https://www.imarcgroup.com/naphtha-market